Acalabrutinib Real World Italian obSErvational Study -ARISE

NCT06205498 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

151

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Lymphocytic Leukemia

Interventions

DRUG: acalabrutinib

Sponsor

AstraZeneca

Collaborators

[object Object]